» Articles » PMID: 25497574

Extensive Clinical, Hormonal and Genetic Screening in a Large Consecutive Series of 46,XY Neonates and Infants with Atypical Sexual Development

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2014 Dec 16
PMID 25497574
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: One in 4500 children is born with ambiguous genitalia, milder phenotypes occur in one in 300 newborns. Conventional time-consuming hormonal and genetic work-up provides a genetic diagnosis in around 20-40% of 46,XY cases with ambiguous genitalia. All others remain without a definitive diagnosis. The investigation of milder cases, as suggested by recent reports remains controversial.

Methods: Integrated clinical, hormonal and genetic screening was performed in a sequential series of 46, XY children, sex-assigned male, who were referred to our pediatric endocrine service for atypical genitalia (2007-2013).

Results: A consecutive cohort of undervirilized 46,XY children with external masculinization score (EMS) 2-12, was extensively investigated. In four patients, a clinical diagnosis of Kallmann syndrome or Mowat-Wilson syndrome was made and genetically supported in 2/3 and 1/1 cases respectively. Hormonal data were suggestive of a (dihydro)testosterone biosynthesis disorder in four cases, however no HSD17B3 or SRD5A2 mutations were found. Array-CGH revealed a causal structural variation in 2/6 syndromic patients. In addition, three novel NR5A1 mutations were found in non-syndromic patients. Interestingly, one mutation was present in a fertile male, underlining the inter- and intrafamilial phenotypic variability of NR5A1-associated phenotypes. No AR, SRY or WT1 mutations were identified.

Conclusion: Overall, a genetic diagnosis could be established in 19% of non-syndromic and 33% of syndromic cases. There is no difference in diagnostic yield between patients with more or less pronounced phenotypes, as expressed by the external masculinisation score (EMS). The clinical utility of array-CGH is high in syndromic cases. Finally, a sequential gene-by-gene approach is time-consuming, expensive and inefficient. Given the low yield and high expense of Sanger sequencing, we anticipate that massively parallel sequencing of gene panels and whole exome sequencing hold promise for genetic diagnosis of 46,XY DSD boys with an undervirilized phenotype.

Citing Articles

Molecular genetic diagnosis and surgical management in a cohort of children with 46,XY disorders/differences of sex development.

Wong Y, Luk H, Yau H, Wong L, Poon S, Tung J Front Pediatr. 2025; 13:1456227.

PMID: 39936125 PMC: 11810906. DOI: 10.3389/fped.2025.1456227.


Characterization of 35 Novel NR5A1/SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study.

Elzenaty R, Martinez de Lapiscina I, Kouri C, Sauter K, Sommer G, Castano L J Clin Endocrinol Metab. 2024; 110(3):e675-e693.

PMID: 38623954 PMC: 11834716. DOI: 10.1210/clinem/dgae251.


El laboratorio en el diagnóstico multidisciplinar del desarrollo sexual anómalo o diferente (DSD): III) Marcadores bioquímicos y genéticos en los 46,XY IV) Propuestas para el diagnóstico diferencial de los DSD.

Granada M, Audi L Adv Lab Med. 2023; 2(4):494-515.

PMID: 37360897 PMC: 10197789. DOI: 10.1515/almed-2020-0120.


The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): I) Physiology, classification, approach, and methodologyII) Biochemical and genetic markers in 46,XX DSD.

Granada M, Audi L Adv Lab Med. 2023; 2(4):468-493.

PMID: 37360895 PMC: 10197333. DOI: 10.1515/almed-2021-0042.


The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): III) Biochemical and genetic markers in the 46,XYIV) Proposals for the differential diagnosis of DSD.

Granada M, Audi L Adv Lab Med. 2023; 2(4):494-515.

PMID: 37360892 PMC: 10197773. DOI: 10.1515/almed-2021-0043.


References
1.
Vizeneux A, Hilfiger A, Bouligand J, Pouillot M, Brailly-Tabard S, Bashamboo A . Congenital hypogonadotropic hypogonadism during childhood: presentation and genetic analyses in 46 boys. PLoS One. 2013; 8(10):e77827. PMC: 3812007. DOI: 10.1371/journal.pone.0077827. View

2.
Kulle A, Riepe F, Melchior D, Hiort O, Holterhus P . A novel ultrapressure liquid chromatography tandem mass spectrometry method for the simultaneous determination of androstenedione, testosterone, and dihydrotestosterone in pediatric blood samples: age- and sex-specific reference data. J Clin Endocrinol Metab. 2010; 95(5):2399-409. DOI: 10.1210/jc.2009-1670. View

3.
van der Zanden L, van Rooij I, Feitz W, Knight J, Donders A, Renkema K . Common variants in DGKK are strongly associated with risk of hypospadias. Nat Genet. 2010; 43(1):48-50. DOI: 10.1038/ng.721. View

4.
Brauner R, Neve M, Allali S, Trivin C, Lottmann H, Bashamboo A . Clinical, biological and genetic analysis of anorchia in 26 boys. PLoS One. 2011; 6(8):e23292. PMC: 3154292. DOI: 10.1371/journal.pone.0023292. View

5.
Ono M, Harley V . Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol. 2013; 9(2):79-91. DOI: 10.1038/nrendo.2012.235. View